Answers are grounded in this paper and cite their sources.
Tumor recurrence in long-term-survival-patients is typically asymptomatic. Especially long-term-survival-patients with lymph vessel invasion are more likely to develop tumor recurrence. Therefore, a structured follow-up program including CT-scans and CA 19-9 surveillance must be continued in all patients undergoing pancreaticoduodenectomy even in cases of long-term-survival.
No takes yet. Share an insight, caveat, or question.
Luu et al. (2021) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: